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Abstract
Bioresorbable silicon electronics technology offers unprecedented opportunities to deploy 
advanced implantable monitoring systems that eliminate risks, cost and discomfort associated with 
surgical extraction. Applications include post-operative monitoring and transient physiologic 
recording after percutaneous or minimally invasive placement of vascular, cardiac, orthopedic, 
neural or other devices. We present an embodiment of these materials in both passive and actively 
addressed arrays of bioresorbable silicon electrodes with multiplexing capabilities, that record in 
vivo electrophysiological signals from the cortical surface and the subgaleal space. The devices 
detect normal physiologic and epileptiform activity, both in acute and chronic recordings. 
Comparative studies show sensor performance comparable to standard clinical systems and 
reduced tissue reactivity relative to conventional clinical electrocorticography (ECoG) electrodes. 
This technology offers general applicability in neural interfaces, with additional potential utility in 
treatment of disorders where transient monitoring and modulation of physiologic function, implant 
integrity and tissue recovery or regeneration are required.
Neurophysiologic monitoring is commonly used for diagnosing and treating neurological 
disorders such as epilepsy, Parkinson's disease, depression, chronic pain and disorders of the 
peripheral nervous system1,2. Such capabilities are critically important for mapping and 
monitoring brain function during and in preparation for resective neurosurgery3, such as for 
epilepsy and tumors, for assisting in neurodevice placement, such as for Parkinson's 
disease4, epilepsy5, and depression, and for guiding surgical procedures on complex, 
interconnected peripheral nerve structures such as the brachial, lumbar and sacral plexi2. 
Related functionality is also increasingly leveraged during intravascular procedures, such as 
aneurysm coiling6, stent placement7, AVM embolization8, and endoscopic operations. Post-
procedure monitoring typically occurs in an intensive care unit (ICU), where a variety of 
devices record physiologic activity, typically with limited temporal and spatial sampling, 
directly at the regions of interest, simply because these are exposed and accessible during 
surgery9. Intracranial monitors for postoperative seizures and recovery of brain function 
after surgery would also be useful, and potentially more sensitive than scalp monitoring10. 
These clinical needs motivate efforts to develop technologies for neurophysiologic 
monitoring that incorporate inorganic and organic nanomaterials in flexible formats11-20. 
Although it would be desirable for neuromonitoring in the ICU to offer the same high 
fidelity, high resolution performance as is available in the operating room, the morbidity and 
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cost of associated with additional surgeries to remove implanted recording devices preclude 
this possibility in general practice. In certain cases, such as in invasive intracranial 
electrocorticographic monitoring for epilepsy surgery, recording electrodes remain in place 
for one to three weeks to localize epileptic networks21. Here, removal occurs in a second 
procedure, often with resection of brain involved in generating seizures. In other cases, 
electrodes are placed in staging procedures that do not end in resection, but rather are done 
for broad lateralization in preparation for more extensive implants or placement of 
implantable devices. Here, a second procedure to remove implants adds cost and risk. 
Recent evidence suggests that 1-3 months of ambulatory intracranial recording may be 
required to adequately localize seizures for epilepsy surgery or device placement, a period 
prohibitively long for current in-hospital approaches22. Using bioresorbable electrodes for 
such studies would eliminate the danger and cost of removing standard electrodes at the end 
of this period, during which standard devices may become fibrosed or adherent to 
underlying tissues. An ideal scenario would involve placement of temporary, bioresorbable 
monitoring devices capable of providing continuous streams of data for guiding medical care 
over predetermined periods of time before dissolving. Below we present a new class of 
technology that offers this mode of operation, with spatio-temporal resolution that matches 
or exceeds any existing alternative.
Recently reported bioresorbable sensors of pressure and temperature in the intracranial space 
provide distinct, complementary capabilities in single-point measurements of non-electrical 
characteristics of the cerebrospinal fluid in the intracranial space23. The results presented 
here introduce materials and device designs for direct electrical interfaces to the brain itself, 
including bioresorbable electrodes and multiplexing electronics for high speed spatio-
temporal mapping of biological processes. The platform builds on recently described 
technologies that exploit nanomembranes of device-grade, monocrystalline silicon (Si NMs) 
as the semiconductor foundation of a high performance class of electronic systems. The key 
enabling chemistry involves hydrolysis of Si NMs upon immersion in biofluids, to yield end 
products that are biocompatible. The results presented here indicate that Si NMs, at high 
levels of doping24, can additionally serve as the neural recording electrodes themselves, as a 
stable, yet ultimately transient, measurement interface. In addition to their established 
bioresorbability, the nanoscale thicknesses of Si NMs, when deployed with thin substrates, 
interconnect metals and dielectrics, yield devices with levels of mechanical flexibility 
necessary for conformal contact and chronically stable interfaces with neural tissues. The 
following content describes means to exploit these concepts in materials, devices and 
system-level examples of bioresorbable Si electronic interfaces to the brain, with examples 
in passive and active matrix addressed recording in vivo. Evaluations include capture of 
ECoG and subdermal encephalograms (EEG) in live, awake animal models, where Si NMs 
serve as active materials both for the recording interface and for the backplane transistors 
that allow high speed multiplexed addressing across arrays of channels. Comprehensive in 
vitro and in vivo studies establish that these systems provide accurate and reproducible 
measurements of neural signals and physiological activity for acute (~hours) and chronic (up 
to 33 days) use. Biocompatibility studies reveal no overt tissue reactions compared to 
clinically approved commercial ECoG electrodes.
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Figure 1a provides an exploded schematic diagram (left) of a magnified optical microscope 
image of the active sensing and the passivation regions (right) of a simplest embodiment of 
these concepts: a thin, flexible electrode array based on phosphorus doped (impurity 
concentrations: ~ 1020 /cm3) collection of Si NM (thickness ~300 nm) structures. Here, a 
layer of SiO2 (thickness ~100 nm) insulates the connection traces to isolate them from bio-
fluids and adjacent tissue. The terminal pads consist of exposed Si, as the direct neural 
interface. A flexible sheet of the bioresorbable polymer poly(lactic-co-glycolic acid, PLGA, 
thickness ~30 μm) serves as the substrate. This array (3 × 4 mm2) allows chronic recordings 
from rat cortex at four measurement sites, each with dimensions of 250 × 250 μm2. Such 
small arrays serve effectively in demonstrator experiments and studies of the fundamental 
issues in the materials science. We note, however, that the materials and fabrication schemes 
align with those used in the semiconductor industry and are, as a result, immediately 
scalable to much larger areas, higher channel counts and smaller/larger electrode sizes. As 
an illustration, Figure 1b (bottom frames) presents a passive array that includes 256 
independent channels, in a 16 × 16 configuration, with an overall area of 3 cm × 3.5 cm. 
Multiplexing architectures, described subsequently, provide routes to scaling to even higher 
numbers of channels. The fabrication steps appear in the methods section and in 
Supplementary Fig. 1. The lot and functional electrode yields are ~100% and >90%, 
respectively. Figures 1b (top) and Supplementary Fig. 2 show micrographs of completed 
arrays. Figure 1b (bottom) shows a scaled version of this same basic device architecture that 
includes 256 independent channels.
Placing an array onto a hydrogel substrate (Fig. 1c) and immersing the system in phosphate-
buffered saline (PBS) at physiological pH (7.4) and at room temperature enables 
characterization of each of the electrodes by electrochemical impedance spectroscopy (EIS), 
across a range of frequencies most relevant to the studies described subsequently. In the 
recording of brain signals, the electrodes transduce ionic currents in the electrolyte to an 
electric current in the measurement system. The contact between an electrode and tissue has 
associated electrical impedance, where reductions in the impedance decrease the noise level, 
thereby increasing the signal to noise ratio (SNR) of the recordings19,25. The data in Fig. 1d 
correspond to the impedance (|Z|) of each channel in the array, along with the response of a 
gold (Au) electrode with the same dimensions. The EIS data for Si can be fit to an 
equivalent Randles circuit model (Supplementary Fig. 3a) that includes a double layer 
capacitance (CPE) in parallel with a charge transfer resistance (RCT), all of which is in series 
with a resistance (RS) that corresponds to the surrounding electrolyte solution. This model 
quantitatively captures the EIS data for both Au (without the space charge layer) and Si 
electrodes, as shown in Supplementary Fig. 3b. The fitted values of CPE are ~2.5 μF/cm2 and 
~10 μF/cm2 for Si and Au, respectively; both values are in a range consistent with the 
literature26,27. The space charge layer lowers the capacitance of the Si electrode28, causing 
the difference in capacitances for Au and Si electrodes (Fig. 1 d). More details of in vitro 
experiments of the Si electrodes are described in Supplementary Note 1 and Supplementary 
Figs 4-7.
The slow, controlled dissolution of Si NMs is critically important in their use as 
bioresorbable neural interfaces. Bioresorbable metals are less attractive options due to their 
comparatively fast dissolution kinetics, and tendency to crack, fragment and flake during the 
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process. Si dissolves under physiological conditions by hydrolysis to yield silicic acid, at 
rates that depend strongly on ionic content of the surrounding solution, pH, temperature and 
other factors, including the doping level. Specifically, Si forms neutral ortho-silicic acid 
Si(OH)4 through an initial oxidation step to SiO2 or through a direct equilibrium Si+4H2O 
↔ Si(OH)4+2H229,30. Figure 1e illustrates the dissolution kinetics for highly boron and 
phosphorus doped (concentration of ~1020 /cm3) Si NMs (~300 nm thick) in artificial 
cerebrospinal fluid (aCSF, pH 7.4) at physiological temperature (37 °C), evaluated by 
measuring the thicknesses at different time points by profilometry (Dektak, USA). 
Observations indicate that dissolution occurs in an exceptionally controlled, predictable 
process, without cracks, flakes, particulates or reduction in surface smoothness that often 
occurs in dissolution of metals. The dissolution rate exhibits a constant, thickness 
independent value of ~11 nm/day for these conditions. The dissolution characteristics of the 
other materials in the system, which for the case of the simple device in Fig. 1 are SiO2 and 
PLGA, are also important, although less critical than the Si NMs due to their passive role in 
the device operation. Measurements indicate that SiO2 and PLGA (75:25)31 dissolve in 
biofluids at 37 °C at rates of ~8.2 nm/day (Supplementary Fig. 8), and complete dissolution 
time scales of ~4-5 weeks, respectively. Results of accelerated dissolution tests appear in 
Figure 1g as a series of images of a complete device collected at various times after 
immersion in PBS pH 10 at 37 °C. We estimate that the current device designs and material 
choices allow complete dissolution of the device in 2 months. Si and SiO2 will dissolve 
within a month and 2 weeks, respectively, followed by PLGA. PLGA will dissolve in ~4-5 
weeks. The materials parameters (i.e., thicknesses, doping levels for the Si, and ratio of 
lactide to glycolide for the PLGA) can be adjusted to achieve desired dissolution times.
For conformal contact against the curved surface of the brain, thin geometries and optimized 
mechanical layouts are important. Three dimensional finite element modeling (FEM) reveals 
distributions of principle strain for bending perpendicular to the interconnect direction, as in 
Fig. 1f (left). Based on the layouts and the mechanical moduli, the maximum strains in the 
SiO2, Si and PLGA are less than 0.03 % for a bending radius of 1 mm, corresponding to the 
linear elastic regime for each of these materials. An optical image of a device wrapped 
around a glass rod with a radius of curvature of ~2 mm appears in Fig. 1f (right). 
Measurements before and after bending show negligible differences in impedance, 
consistent with expectation based both on FEM and analytical modeling results 
(Supplementary Fig. 9).
In vivo neural recording experiments involved the bioresorbable devices of Fig. 1 in adult rat 
animal models anesthetized and placed in a stereotaxic apparatus. A craniotomy exposed a 
4×8 mm2 region of cortex in left hemisphere (Fig. 2a), to allow positioning of a device on an 
area of the cortical surface next to a standard stainless steel microelectrode (7,850 μm2) as a 
control for recording physiological oscillations under isofluorene anesthesia. Figure 2b 
shows representative sleep spindle activity captured by one of the channels in the 
bioresorbable array and the control electrode. Supplementary Fig. 10 show similar data for 
brain waves recorded during transition to deep anesthesia (Supplementary Fig. 10a) and K-
complexes (Supplementary Fig. 10b) measured under anesthesia. Representative examples 
of pre-ictal and ictal-like spiking epileptiform activity induced by application of crystals of 
bicuculline methoxide recorded by the bioresorbable electrode and the control electrode 
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appear in Fig. 2c and d, respectively. The frequency of the pre-ictal spikes (Fig. 2c) increases 
and the inter-spike duration decreases as the time progresses, terminating into after 
discharges and ictal-like early epileptic discharges (Fig. 2d). The bioresorbable arrays can 
also be utilized as subdermal implants for high fidelity, recording of EEG and evoked 
potentials. Devices implanted on periosteum as described in Fig. 2e and Supplementary Fig. 
11 yielded reliable recordings of theta waves (highlighted in power spectral analysis) and 
sleep spindles (Fig. 2f). Collectively, the results demonstrate that bioresorbable recording 
platforms can capture reliable physiological or pathological activity both intracortically and 
subdermally.
Chronic tests of ECoG recording indicate long-term stability in operation, where devices 
with increased thicknesses of SiO2 (~300 nm) and Si NMs (~1000 nm) survive for more 
than one month. Such studies used a miniature interface board connected to the device via a 
flexible interconnect cable to a headstage (Supplementary Fig. 12) designed for use with 
rats. Details are explained in the Methods section. Figure 3 summarizes representative 
cortical potentials recorded by three electrodes in the bioresorbable array and by a nearby 
screw electrode as a control, captured on Days 1, 8, 15, 30, 32 (Supplementary Fig. 13), and 
33 measured from the time of the surgical implantation. Figure 3a and Supplementary Figs 
12 and 14 describe the surgical procedures and the post-surgical setups used in freely 
moving rats, respectively. ECoG potentials show physiological signals and brain oscillations 
with various temporal and spatial differences. High-amplitude seizure-like rhythmic spike 
discharges (Fig. 3g) appear occasionally, consistent with absence-like seizure activity 
observed in Long Evans Rats32-34. By all functional metrics (e.g. signal to noise ratio, ability 
to measure delta, theta, alpha, gamma, spindles and sometimes epileptic spikes), the devices 
operate in a stable fashion, largely without change in performance throughout the month of 
the study, until sudden failure, likely due to the development of an open circuit state in the 
vicinity of the interconnects. After day 33, signals from the bioresorbable device disappear; 
while those form the control persist, consistent with dissolution of at least some critical 
component of the device. For epilepsy patients the clinically relevant operational lifetime is 
several weeks. Here, bioresorbable devices could be embedded into particular clinical 
devices to monitor for early signs of failure during critical post-operative periods, such as 
measuring pressure and flow after intravascular aneurysm occlusion (coiling), placement of 
aortic or other vascular grafts, or procedures to seal cerebrospinal fluid (CSF) leaks. 
Currently monitoring is based upon clinical examination, or requires interventional 
radiology that is invasive, expensive and impractical for continuous monitoring over days to 
months.
Understanding the reactive tissue response is critical in assessing the potential for use in 
such clinical applications35. Tissue inflammation, encapsulation of the electrodes in fibrous 
tissue (glial scar) and neuronal death in the vicinity of the electrode are the most important 
issues related to clinical translation36-38. Studies of tissue reactions of bioresorbable 
electrode arrays involved chronic implants in 14 animals, with Pt electrodes cut into similar 
geometries from clinical subdural grids (Ad-Tech Medical Inc) as controls, as shown in 
supplementary Fig. 15. Figure 4 summarizes the results obtained according to procedures 
outlined in the methods section. Double label immunohistochemistry for GFAP and Iba-1 
reveal glial cell activation at 4 weeks post-implant (Fig. 4). In both control and bioresorbable 
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devices, moderate subpial gliosis occurs at the implantation site, when compared to the 
control contralateral hemisphere. No significant astrogliosis is noted at distant sites within 
the ipsilateral hemisphere. Iba-1 immunohistochemistry demonstrates the presence of both 
resting ramified, as well as round activated microglia underneath the control electrode, 
which extends to the superficial layers I-III. In contrast, at the implantation site of the 
bioresorbable electrode, microglial cells show an almost exclusively ramified morphology. 
The contralateral side in both groups exhibits no microglial reaction. The sham-operated 
control demonstrates a similar moderate subpial gliosis, but with no change in microglial 
densities or morphology.
Actively multiplexed device designs enable high-resolution, high channel count neural 
interfaces by minimizing the number of wires needed for external data acquisition. In this 
context, Si NMs provide not only an excellent choice for the electrodes but also for the 
backplane electronics, including the necessary switching and buffer transistors as a scalable 
pathway toward systems with increased numbers of channels and area coverage. A fully 
bioresorbable design appears in Fig. 5a; a sequence of images at various stages of the 
fabrication appear on the right. This embodiment uses 128 n-channel metal-oxide-
semiconductor field-effect transistors (MOSFETs), with Molybdenum (Mo) for the source, 
drain and gate electrodes, and SiO2 (~100 nm) for the gate dielectrics. Additional layers of 
Mo and a trilayer of SiO2 (~300 nm)/Si3N4 (~400 nm)/SiO2 (~300 nm) form interconnects 
and interlayer dielectrics (ILD), respectively. A second layer of Mo (~300 nm) serves as 
column selects and additional sensing electrode pads. Another trilayer provides a blanket 
encapsulating layer that has openings only at the locations of the Mo interface electrodes. 
The amount of materials in a single device with active multiplexed addressing are 100 mcg 
of Mo, 1.43 mcg of Si, 306 mcg of SiO2, 264 mcg of S3iN4, and 27 pg of P. For comparison, 
the daily intake limits, average daily intake values, and daily production of such materials 
appear in Supplementary Table 1. The chemistry, dissolution kinetics and biocompatibility 
of each of the constituent materials can be found elsewhere39-46. The lot and functional 
electrode yields are ~10-20% and ~80%, respectively. Failures arise from leakage currents 
associated with pinholes in the encapsulating layer, introduced by particulate contamination 
in our academic cleanroom facilities. Figure 5b presents photographs of a device, wrapped 
around a cylindrical tube, with an inset that shows arrays of active electrodes. Figure 5c 
summarizes the electrical properties of a representative n-type MOSFET, where the mobility 
and on/off ratio are ~400 cm2 V−1 and ~108, respectively, as calculated using standard field-
effect transistor models. Figure 5d shows in vitro measurements on a representative unit cell. 
The output response was consistent with the input signal, thereby indicating proper 
operation. Details of in vitro experiments are in Supplementary Note 2 and Supplementary 
Figs 16-20.
Figure 5e shows a sequence of images during accelerated dissolution in PBS pH 12 at 37 °C. 
PECVD Si3N4 and Mo40, 41 dissolves in biofluids at pH 7.4 at 37 °C at a rate of ~5.1 
nm/day (Supplementary Fig. 8) and ~16-25 nm/day, respectively. This system involves ~1.3 
μm, ~800 nm, ~300 nm, ~600 nm and ~30 μm thick layers of PECVD SiO2, Si3N4, Si, Mo 
and PLGA, respectively. PLGA, Si, and Mo in biofluids at 37 °C dissolve completely within 
in ~4-6 weeks. Both SiO2 and Si3N4, dissolve in 6 months under the same conditions. 
Supplementary Fig. 20 shows results of measurements of gain across the array and 
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cumulative leakage current for a representative device immersed in PBS at pH 7.4. The 
average gain and yield were 94% and 100%, respectively.
Figure 6 provides details on in vivo recordings with a bioresorbable, multiplexed recording 
array. The leakage current is ~10 nA. The 64-electrode array was placed on the cortical 
surface of the left hemisphere of an anesthetized rat in a stereotaxic apparatus 
(Supplementary Fig. 21). Picrotoxin was applied topically to induce epileptiform activity, 
just prior to the placement of the array. The data reveal epileptic spikes and discharges that 
last ~1-3s (Supplementary Movie 1) and repeat every ~10-15s. A set of different epileptic 
spikes (clockwise spiral, lower right to upper left diagonal, upper left to lower right 
diagonal, and right to left sweep) is shown in Fig. 6a as representative recordings. The 
sequence of eight movie frames corresponding to each spike (Fig. 6b) clearly reveals the 
propagation of neural waves and associated spatial-temporally resolved patterns 
(Supplementary Movie 2-6). The delay maps represent the latency of the spike's peak at each 
site (Fig. 6c). Each spiking activity shows a distinctive spatial flow indicated by the yellow 
arrow in each delay map. RMS power maps, corresponding to each representative spike (Fig. 
6c and Supplementary Fig. 22) show the spatially resolved patterns.
In addition to epileptiform activity, spatial distributions of low amplitude evoked cortical 
activity can be captured using the same device. Somatosensory evoked potential (SSEP) 
experiments were conducted in anesthetized rats using the bioresorbable multiplexed array 
on the surface of the exposed barrel cortex. Evoked potentials were produced by stimulating 
two different whiskers (B1 and E3, Fig. 6d), corresponding to the barrel cortex and 
estimated relative location (Fig. 6e). The temporally resolved patterns of the evoked 
potentials are shown in Fig. 6f. The spatial distribution of the amplitude of the evoked 
potentials measured at the cortical surface by the array is consistent with the relative location 
of the activated whiskers on the barrel cortex as described with the color map (Fig. 6g). 
These results collectively demonstrate an ability to record stimulus evoked and drug-induced 
neural activity with high SNR. The same materials and device architectures can be easily 
adapted to larger areas and increased channel counts with potential for use in large animal 
models and, in the future, for clinical monitoring applications.
The concepts introduced here form a robust foundation of capabilities in bioresorbable 
implantable electrode technology for various clinical problems, ranging from post-operation 
monitoring of brain activity to electrical monitoring of skeletal muscles or organ function. In 
all cases, the thin, flexible form factors minimize mechanical injury associated with 
implantation and chronic use. The use of Si as the active semiconductor material aligns the 
technology consumer electronics industry with the natural capacity to scale to higher 
densities of electrodes and larger areas.
 METHODS
 Fabrication of passive electrode arrays
Fabrication of the passive electrode arrays began with solid state phosphorus doping 
(PH-1000N Source, Saint Gobain, USA, 1000 °C for 10 minutes) of p-type device Si on a Si 
on insulator (SOI, top Si ~300 nm, SOITEC, France) wafer. Removing the buried oxide 
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layer of the SOI by wet etching with concentrated HF released the device Si as a Si NM, 
retrieved with a slab of the elastomer poly(dimethylsiloxane) (PDMS) and transfer-printed to 
a spin-cast bilayer of poly(methylmethacrylate) (PMMA, ~800 nm thick) and polyimide (PI, 
~300 nm thick) on a Si wafer. Photolithography and reactive ion etching (RIE) defined a 
pattern of electrodes and interconnects in the Si NMs. Plasma enhanced chemical vapor 
deposition (PECVD) formed a layer of SiO2 (thickness 100 nm) as encapsulation. Patterned 
etching with buffered oxide etchant removed the SiO2 from the electrode regions. Spin 
casting and patterning a top coating of PI (~300 nm thick) placed the Si NM electrodes and 
interconnects near the neutral mechanical plane. Patterning a mesh structure across the 
multilayer (i.e. PI, SIO2, PI and PMMA) by RIE followed by immersion in buffered oxide 
etchant exposed the base layer of PMMA to allow its dissolution in acetone. Retrieval onto a 
slab of PDMS enabled removal of the bottom exposed layer of PI by RIE. Transfer onto a 
film of PLGA (~30 μm thick), facilitated by heating to temperatures close to the glass 
transition of the PLGA (55~60 °C, lactide/glycolide ratio of 75:25 composition), followed 
by elimination of the top layer of PI by RIE completed the fabrication. Bonding an ACF 
cable to the terminal regions of the Si NM interconnects yielded connection points for 
interfaces to external data acquisition (DAQ) systems.
 Fabrication of actively multiplexed electrode arrays
The fabrication began with growth of 200 nm of thermal oxide on a p-type SOI wafer (top Si 
~320 nm, SOITEC), photolithography and immersion in buffered oxide etchant to create a 
mask for solid state phosphorus diffusion (1000 °C for 6 minutes) to define the source and 
drain contacts. Releasing, retrieving and transferring the doped Si NMs onto a temporary 
substrate, consisting of Si wafer with a bilayer coating of PI/PMMA, followed procedures 
similar to those described for passive electrode arrays. Photolithography and RIE etching 
patterned the Si NMs into geometries for an 8×8 array of unit cells, each consisting of two 
transistors connected in series for purpose of actively multiplexed readout. A thin layer of 
SiO2 (PECVD at 220 °C, thickness ~100 nm) served as the gate dielectric. Buffered oxide 
etching through a photolithographically patterned mask formed openings through the SiO2 
to expose the source and drain contact regions. Photolithography and lift off in acetone 
defined a patterned layer of Mo (sputter deposited, thickness ~300 nm) for the gate 
electrodes and metal interconnects. Deposition of a trilayer of SiO2 (~300 nm)/Si3N4 (~400 
nm)/SiO2 (~300nm) by PECVD formed the interlayer dielectric. Photolithography and 
buffered oxide etching created vertical interconnect access (via) holes for electrical 
connections between layers. An additional layer of Mo (thickness ~300 nm) patterned by 
photolithography and liftoff defined column select lines. Another trilayer of SiO2 (~300 
nm)/Si3N4 (~400 nm)/SiO2 (~300nm) served as encapsulation, with openings at the 
locations of the sensing electrodes and peripheral contact pads for interfacing to an external 
DAQ system. A spin-cast layer of PI served as device passivation. Selective RIE and 
buffered oxide etching through these multilayer stacks (diluted PI/trilayers of inorganic 
materials/trilayers of inorganic materials/Diluted PI) formed mesh structures that enabled 
release of active layers from the temporary substrate by dissolving the PMMA layer in 
acetone. Transfer printing steps followed, according to procedures similar to those for the 
passive electrode fabrication.
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 In vivo acute recordings of epileptiform activity
The in vivo data Fig. 2 is representative of four different acute experiments, each of which 
lasted 5-6 hours. The procedures, which were approved by the Institutional Care and Use 
Committee of the University of Pennsylvania, involved an anaesthetized rat with its head 
fixed in a stereotaxic apparatus. Wild-type, adult Long Evans male and female rats were 
used. The animal was anesthetized with initially ketamine/xylazine and then isoflurane 
throughout the craniotomy and neural recordings. A craniotomy exposed a 4×8 mm region 
of cortex in either left or tight or in both hemispheres. All recordings were taken in reference 
to a distant stainless steel bone screw inserted through the skull during the surgery. A 
commercial stainless steel microwire electrode (~100 um stainless steel wire from California 
Fine Wire) placed at 0.5 mm depth from the cortical surface in close proximity to the 
bioresorbable electrodes served as a control during acute recordings. Neural data was 
acquired by a FHC multi-channel neural amplifier (FHC Inc, Bowdoin, ME, USA) and an 
acquisition system (16 bit Axon Instruments Digidata 1322A, Axon Instruments, Foster 
City, CA). Recordings were high pass filtered at 0.1 Hz. Neural recording data were 
analyzed offline using Clampfit software (Axon Instruments) and custom Matlab software 
for neural signal analysis.
 In vivo acute recordings of evoked responses by whisker stimulation
The following procedures were approved by the Institutional Care and Use Committee of the 
University of Pennsylvania. One 150-g, Sprague-Dawley rat was anesthetized with a 
ketamine (60 mg/kg), dexdomitor (0.25 mg/kg) solution and placed in a stereotaxic frame. A 
craniotomy was performed to expose the right barrel cortex. A skull screw was placed in the 
left frontal bone to serve as the reference electrode for the recordings. The recording array 
was placed over the exposed cortical surface. A pair of needle stimulating electrode were 
inserted into the left mystacial pad at various locations. Brief electrical currents (~250-600 
μA, 1 ms/phase, biphasic pulse) were passed between the electrodes to activate the intrinsic 
muscles of the vibrissae, causing a visible protraction of the whiskers. Current amplitude 
and electrode spacing was adjusted for focal activation, usually 1-4 whiskers. Cortical 
potentials evoked by the whisker stimulation were recorded at 781.25 samples/s.
 In vivo chronic recordings
An adult Long Evans rat was anesthetized with isoflurane and placed in a stereotactic frame 
(David Kopf Instruments Tujunga, CA). Body temperature was maintained with a heating 
blanket and the eyes were covered with ointment to prevent drying. The skull was exposed 
and a large craniotomy (4 × 8 mm2) was made between bregma and lambda and laterally to 
the midline. The electrode was placed on the exposed dura and a slurry of gel foam and 
saline was layered on top of the electrode. A screw electrode was placed contralaterally to 
the experimental array, with another such electrode placed posterior to lambda as a ground 
and reference. Additional screws were secured in the skull for anchoring. The skull and 
electrodes were then covered with dental cement and the connecting plug was secured on 
top. The rat was given meloxicam for postoperative pain and allowed to recover on a heating 
pad. The rat was given meloxicam daily for 3 days after surgery to minimize pain. After 1 
week the animal was placed in a cage for video/EEG recording. EEG signals were collected 
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continuously from 3 channels on the array and from the screw. The signals were amplified 
and low pass filtered at 600 Hz (Multichannel Systems, Reutlingen, Germany) and sampled 
at 2000 Hz with a 16 bit digitizer (National Instruments, Austin, TX). Data was acquired 
using a custom written MATLAB routine.
 Chronic evaluation of immunohistochemistry
Rats (n=14) were anesthetized and transcardiac perfusion was performed using phosphate 
buffered saline (PBS 10x, cat. # BM-220, Boston BioProducts, Ashland, MA), followed by 
4% paraformaldehyde (PFA, cat. # BM-155, Boston BioProducts). Whole brains were then 
removed and post-fixed overnight at 4°C in the same 4% PFA solution. Subsequently, fixed 
brains were cryoprotected in 30% sucrose (cat. # 57-50-1, Sigma-Aldrich, Saint Louis, MO) 
at 4°C and coronal sections were cut at 20 μm using a Leica CM3050 S cryostat (Leica 
Biosystems Inc.). Serial sections, spanning the entire craniotomy site, were mounted on 
charged slides and stored at −20°C until use. For immunostaining, slides were first 
immersed in an antigen retrieval solution (0.1M citrate buffer, pH 6.0, cat# ab64214, Abcam, 
Cambridge, MA) and placed in a water bath at 95°C for 10 minute. After cooling, sections 
were rinsed in distilled water, incubated in a blocking solution containing 0.1% Triton 
X-100 (cat. # 9002-93-1, Sigma-Aldrich) and 5% normal goat serum (cat. # GS-0500, 
Equitech-Bio Inc., Kerrville, TX) for one hour at room temperature (RT) and then incubated 
overnight at 4 °C with the following primary antibodies: anti- Glial Fibrillary Acidic Protein 
(GFAP, 1:1000, cat. # SMI-22R, Covance, Princeton, NJ), and anti-ionized calcium binding 
adapter molecule 1 (Iba-1, 1:1000, cat. # 019-19741, Wako Chemicals USA, Inc., 
Richmond, VA). After 3×20-minute washes in PBS, sections were incubated with the 
corresponding fluorescent secondary antibodies (Alexa Fluor 488 goat anti-mouse IgG2b, 
1:1000, cat. # A-21141, and Alexa Fluor 568 goat anti-rabbit IgG, 1:1000, cat. # A-11011, 
Invitrogen by Life Technologies, Grand Island, NY). After the final washes (3 × 20 min in 
PBS), the slides were cover-slipped with an anti-fade medium containing the nuclear stain 
DAPI (Fluoromount-G+DAPI, cat. # 0100-20, Southern Biotechnology, Birmingham, AL). 
Control sections were incubated with omission of one or both primary antibodies, adding 
only the secondary antibodies to exclude false-positive labeling. Slides were examined on an 
epifluorescence microscope (Zeiss Axioscope, Germany) and images were acquired with a 
20× objective and a Spot RT3 digital camera, using the Spot Software 5.1 (Diagnostic 
Instruments, Sterling Heights, MI). Digital images were processed using Adobe Photoshop 
12.0 (Adobe Systems, San Jose, CA).
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Thin, flexible neural electrode arrays with fully bioresorbable construction based on 
patterned silicon nanomembranes (Si NMs) as the conducting component
a, Schematic exploded view illustration of the construction of a passive, bioresorbable neural 
electrode arrays for ECoG and sub-dermal EEG measurements. A photolithographically 
patterned, n-doped Si NMs (~300 nm thick) defines the electrodes and interconnects. A film 
of SiO2 (~100 nm thick) and a foil of PLGA (~30 μm thick) serves as a bioresorbable 
encapsulating layer and substrate, respectively. The device connects to an external data 
acquisition (DAQ) system through an anisotropic conductive film interfaced to the Si NMs 
interconnects at contact pads at the edge. A magnified optical image of electrodes on the 
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right highlights the sensing (Si NMs) and insulating (SiO2) regions. b, Photographs of 
bioresorbable neural electrode arrays with 4 channels (top) and 256 (16 × 16 configuration) 
channels (bottom). c, Microscope image of a device on a hydrogel substrate immersed in an 
aqueous buffer solution (pH 7.4) at 37 °C. d, Electrochemical impedance spectra measured 
at four different recording sites in an array configured for ECoG. e, Dissolution kinetics for 
phosphorus and boron doped Si NMs (~300 nm thick, dopant concentration 1020 /cm3) 
during immersion in artificial cerebrospinal fluid (aCSF) pH 7.4 at 37 °C. f, Distribution of 
principal strains extracted from finite-element modeling (FEM) of a device bent to a radius 
of curvature of 1 mm (center) and corresponding displacement profile (left) and image of an 
array wrapped around a cylindrical tube with a radius of 2 mm (right). g, Images collected at 
several stages of accelerated dissolution induced by immersion in an aqueous buffer solution 
(pH 10) at 37 °C.
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Figure 2. In vivo neural recordings in rats using a passive, bioresorbable electrode array
The data presented here are representative of three separate acute experiments, each with a 
duration of ~5-6 hours. a, Photograph of four-channel bioresorbable electrode array placed 
on the cortical surface of the left hemisphere of a rat. b, Sleep spindles recoded by a 
bioresorbable electrode and a nearby commercial stainless steel microwire electrode, as a 
control placed at 0.5 mm depth from the cortical surface. c, Interictal spiking activity 
captured by the bioresorbable electrode and the control electrode after topical application of 
bicuculine methodide. Both electrodes interface with the same hemisphere. Data were 
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processed through a 0.1 Hz-5 kHz bandpass filter. Recordings by the bioresorbable electrode 
and the control electrode show consistent interictal spikes. d, Interictal spiking activity 
recorded by the bioresorbable electrode and the control electrode 30 minutes after topical 
application of bicuculine methodide. Both recordings exhibit high signal-to-noise ratio (Si: 
42, Control electrodes: 32) for detecting epileptiform activity. e, Cartoon illustration of a 
bioresorbable array placed on the periosteum for subdermal EEG recordings. f, Theta 
oscillations and fast spindle-like oscillations recorded subdermally using bioresorbable 
electrodes during isoflurane anesthesia. g, Power density spectra of the theta oscillations 
recorded over a 5 min time window. The spectrum shows a clear peak at the expected 
frequency range.
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Figure 3. In vivo chronic recordings in rats using a passive, bioresorbable electrode array
The data presented here is representative of chronic recording experiments with a duration of 
30 days. a, Photograph of a four-channel bioresorbable electrode array implanted on left 
hemisphere of the brain of a rat, for chronic recordings, with a coating gelfoam and a layer 
of dental cement. The array connects to a custom-built circular interface board through a 
flexible ACF cable. The inset shows the array and craniaotomy after application of a first 
layer of dental cement. b-f, Representative ECoG signals recorded by the bioresorbable 
array and the control electrode on day 1, 8, 15, 30 and 33. Recordings from three electrodes 
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from the bioresorbable array exhibit large scale oscillatory behavior consistent with small 
local and temporal variations. After functional dissolution (Day 33), signals from the 
bioresorbable array show no ECoG activity while the control electrode continues to show 
expected cortical potentials. g, High voltage rhythmic spikes observed during absence-like 
seizure activity recorded chronically.
Yu et al. Page 19
Nat Mater. Author manuscript; available in PMC 2016 October 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. Immunohistology analysis
Double labeling for astrocytic marker GFAP (green) and microglia/macrophages marker 
Iba-1 (red) demonstrates moderate subpial gliosis at the implantation sites of both control (a, 
upper left panels) and bioresorbable (b, upper right panels) electrodes and a marked increase 
in the densities of activated round microglial cells, exclusively underneath the control 
electrodes (middle left panels). Cell nuclei are visualized with DAPI stain (blue). Scale bars 
represent 30 μm.
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Figure 5. Bioresorbable actively multiplexed neural electrode array
a, Schematic exploded view illustration of an actively multiplexed sensing system for high 
resolution ECoG, in a fully bioresorbable construction. This 8 × 8 embodiment includes 128 
metal-oxide-semiconductor field-effect transistors (MOSFETs) where Si NMs serve as both 
the active semiconductor material and the neural interface electrodes. The metallization, the 
gate dielectric and the interlayer dielectric rely on thin films of Mo (~300 nm thick) and 
SiO2 (~100 nm thick) and trilayers of SiO2 (~300 nm thick) / Si3N4 (~400 nm thick) /SiO2 
(~300 nm thick), respectively. A second layer of Mo (~300 nm thick) defines column 
interface lines. A similar trilayer serves as the encapsulation. A film of poly(lactide-co-
glycolide) (PLGA, ~30 μm thick) forms the substrate. b, Optical micrograph images of a 
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pair of unit cells at various stages of fabrication (left) and a picture of a complete system 
(right). c, The left frame shows linear (red) and log scale (blue) transfer curves for a 
representative n-channel MOSFET, for Vg swept from −5 to +5 V. The channel length (Lch), 
and width (W) are 15 μm and 80 μm, respectively. The threshold voltage, mobility and 
on/off ratio are ~1 V, ~400 cm2/V·s and ~108, respectively, with Mo for source, drain and 
gate electrodes, and SiO2 for gate dielectrics. The right frame shows current-voltage 
characteristics, for Vg from 0 to 2.5 V with 0.5 V steps. d, Output response of a unit cell 
with respect to an input sine wave (200 mV peak to peak) upon insertion in aqueous 
phosphate buffer solution (PBS, pH 7.4) at room temperature. e, Images collected at several 
stages of accelerated dissolution of a system immersed into an aqueous buffer solution (pH 
12) at 37 °C.
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Figure 6. Acute in vivo microscale electrocortigoraphy (μECoG) with a 64-channel, 
bioresorbable, actively multiplexed array of measurement electrodes
a, Data recorded from picrotoxin-induced spikes (clockwise spiral, lower-right to upper-left 
diagonal, upper-left to lower-right diagonal, and right-to-left sweep). The results correspond 
to measurements across the 64 channels of the array, and the average response (grey) from 
all channels. The waveforms are color-coded according to the relative latency of the spike 
maximum (blue is earliest, red is latest). b, Movie frames corresponding to each spike 
pattern, showing the varied spatial-temporal μECoG voltage patterns from all 64 electrodes 
at the labeled time. Blue indicates negative, and dark red indicates the highest peak-to-peak 
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voltage observed for each electrode site. The frame interval and color scale are provided for 
each set of eight movie frames. c, Relative delay map for the band-pass filtered data of each 
spike activity from frame b, illustrating a clear phase singularity indicated by arrow. d, 
Illustration of the whisker stimulation locations (Stim. loc.: B1 and Stim. loc.: E3) in a rat 
model. e, Illustration of the barrel cortex and estimated relative location of the recording 
array based on evoked potential results. Visibly-activated whiskers indicated by color 
corresponding to the stimulation location. M = medial, C = caudal. f, Temporal 
characteristics of the potentials evoked by stimulation location 1 (left) and 2 (right). 
g,Spatial distribution of the potentials evoked by stimulation location 1 and 2. The color map 
indicates the evoked potential size, interpolated across the array.
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